Mats WikstroemSenior Principal Scientist at Amgen
I have research and management experience from several academic research institutions and pharmaceutical companies such as Lund University, Sweden, National Institutes of Health (NIH), United States, Pharmacia and Upjohn Company, Sweden/United States , Biovitrum Company, Karolinska Institute, Sweden, University of Copenhagen, Denmark, and Amgen Inc, United States. My research interest has been focused on deciphering the molecular details in protein-protein interactions. This work has involved functional and structural studies of virulence determinants of several bacterial pathogens, including the discovery of novel virulence determinants of Streptococcus pyogenes, employing both NMR spectroscopy in solution and X-ray crystallography.
I am currently leading the higher order structure (HOS) group at Amgen Inc, Thousand Oaks, United States.